Cobb and Douglas Public Health workers get Moderna vaccine

Cobb Douglas Public Health Moderna vaccine
CDPH staff member Nicholas Hayes administers COVID-19 vaccine at the Marietta Public Health Center.

Submitted information and photo:

Cobb & Douglas Public Health (CDPH) has received the first doses of the COVID-19 vaccine and began providing vaccinations to staff wishing to be vaccinated on the CDPH Marietta campus. This will be followed by vaccine administration to district healthcare personnel working on the front lines of the pandemic, and residents of local long-term care facilities, starting this week.

According to the Georgia Department of Public Health, as of Dec. 22, more than 125,000 doses of the Pfizer vaccine and more than 30,000 doses of the Moderna vaccine have been shipped to Georgia.

Janet Memark, MD, District Health Director said, “After 10 very long months of fighting this virus on the front lines, CDPH is so excited to be able to provide some protection to our district healthcare workers so that they can continue to serve our residents while also protecting themselves and their families.”

A spokeswoman for Cobb and Douglas Public health could not say how many doses were administered, and to how many employees, but said the vaccinations will continue for frontline workers this week.

Doses of the Moderna vaccine also will go to organizations like CORE (Community Organized Relief Effort), which partners with CDPH to conduct COVID testing.

She said other doses will be distributed “to independent healthcare providers who have not secured their own supply.”

Related content

 

Get Our Free E-Mail Newsletter!

Every Sunday we round up the week’s top headlines and preview the upcoming week in the East Cobb News Digest. Click here to sign up, and you’re good to go!

2 thoughts on “Cobb and Douglas Public Health workers get Moderna vaccine”

  1. I want to get,appointment for vaccine n all I am not able to please call me. I do not have computer and limited with cell 210 ,383. 3052. Is my number

Comments are closed.